BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20729256)

  • 1. Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study.
    Amato MP; Portaccio E; Goretti B; Zipoli V; Iudice A; Della Pina D; Malentacchi G; Sabatini S; Annunziata P; Falcini M; Mazzoni M; Mortilla M; Fonda C; De Stefano N;
    Mult Scler; 2010 Dec; 16(12):1474-82. PubMed ID: 20729256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
    Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
    Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment.
    Portaccio E; Amato MP; Bartolozzi ML; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
    J Neurol Sci; 2006 Jun; 245(1-2):195-9. PubMed ID: 16631794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
    Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
    Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis.
    Patti F; Amato MP; Bastianello S; Caniatti L; Di Monte E; Ferrazza P; Goretti B; Gallo P; Morra VB; Lo Fermo S; Picconi O; Tola MR; Trojano M;
    Mult Scler; 2010 Jan; 16(1):68-77. PubMed ID: 19995846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
    Gioia MC; Cerasa A; Liguori M; Passamonti L; Condino F; Vercillo L; Valentino P; Clodomiro A; Quattrone A; Fera F
    Brain Res; 2007 Sep; 1167():71-9. PubMed ID: 17689504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment in multiple sclerosis: a longitudinal study.
    Amato MP; Ponziani G; Amaducci L
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():465-8. PubMed ID: 10689495
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence of cognitive compensation associated with educational level in early relapsing-remitting multiple sclerosis.
    Bonnet MC; Deloire MS; Salort E; Dousset V; Petry KG; Brochet B;
    J Neurol Sci; 2006 Dec; 251(1-2):23-8. PubMed ID: 17097108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.
    Calabrese M; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Romualdi C; Rinaldi L; Perini P; Gallo P
    Neurology; 2010 Jan; 74(4):321-8. PubMed ID: 20101038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
    Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive deficits in multiple sclerosis patients with cerebellar symptoms.
    Valentino P; Cerasa A; Chiriaco C; Nisticò R; Pirritano D; Gioia M; Lanza P; Canino M; Del Giudice F; Gallo O; Condino F; Torchia G; Quattrone A
    Mult Scler; 2009 Jul; 15(7):854-9. PubMed ID: 19542264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of cortical lesions in MS: relation with cognitive impairment.
    Roosendaal SD; Moraal B; Pouwels PJ; Vrenken H; Castelijns JA; Barkhof F; Geurts JJ
    Mult Scler; 2009 Jun; 15(6):708-14. PubMed ID: 19435749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome.
    Khalil M; Enzinger C; Langkammer C; Petrovic K; Loitfelder M; Tscherner M; Jehna M; Bachmaier G; Wallner-Blazek M; Ropele S; Schmidt R; Fuchs S; Fazekas F
    Mult Scler; 2011 Feb; 17(2):173-80. PubMed ID: 20956399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive compensation failure in multiple sclerosis.
    Bonnet MC; Allard M; Dilharreguy B; Deloire M; Petry KG; Brochet B
    Neurology; 2010 Oct; 75(14):1241-8. PubMed ID: 20921510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis.
    Mathiesen HK; Jonsson A; Tscherning T; Hanson LG; Andresen J; Blinkenberg M; Paulson OB; Sorensen PS
    Arch Neurol; 2006 Apr; 63(4):533-6. PubMed ID: 16606765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial.
    Schwid SR; Goodman AD; Weinstein A; McDermott MP; Johnson KP;
    J Neurol Sci; 2007 Apr; 255(1-2):57-63. PubMed ID: 17331542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.
    Rovaris M; Agosta F; Sormani MP; Inglese M; Martinelli V; Comi G; Filippi M
    Brain; 2003 Oct; 126(Pt 10):2323-32. PubMed ID: 12937086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis.
    Sundgren M; Maurex L; Wahlin Å; Piehl F; Brismar T
    Arch Clin Neuropsychol; 2013 Mar; 28(2):144-55. PubMed ID: 23291310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive deficits in multiple sclerosis correlate with changes in fronto-subcortical tracts.
    Roca M; Torralva T; Meli F; Fiol M; Calcagno M; Carpintiero S; De Pino G; Ventrice F; Martín M; Vita L; Manes F; Correale J
    Mult Scler; 2008 Apr; 14(3):364-9. PubMed ID: 18208880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.